Veeva Gains Leadership Position as Another Biopharma Giant Chooses Vault CRM

Veeva Leads the Way with Vault CRM in Biopharmaceutical Sector

In a significant boost to its market position, Veeva Systems (NYSE: VEEV) announced on September 23, 2026, a fresh commitment from one of the top 20 companies in the biopharmaceutical sector. This development is part of a broader trend, as notable companies such as Amgen, Biogen, Eli Lilly and Company, and Regeneron have also recently selected Veeva's Vault CRM. With over 190 active clients and commitments from 14 of the 20 largest biopharmaceutical firms worldwide, Vault CRM stands out as the premier choice for enterprises looking to enhance their productivity and operational efficiency.

What is Vault CRM?

Vault CRM is not just a customer relationship management tool; it represents the next generation of CRM solutions designed specifically for the biopharmaceutical industry. This ground-breaking platform provides advanced capabilities to bolster the performance of commercial teams in the field. Its innovative features include the Agentic Call Report, which delivers commercial insights that empower sales teams to craft targeted strategies, recognize treatment barriers, and optimize client engagement.

Arno Sosna, the president of the CRM Suite at Veeva, expressed enthusiasm for the ongoing collaboration with their clients, stating, "We are excited to work alongside our clients as Vault CRM aids in the transition to an agentic commercial model. Together, we are establishing a fundamentally new way of working that delivers medicines to patients faster and more effectively."

Transforming Healthcare Interactions

Vault CRM facilitates a transformation in how the biopharmaceutical industry interacts with healthcare professionals. By bringing together sales and marketing functionalities, it ensures that all communications are efficient, client-centered, and compliant across multiple channels.

The platform is part of the larger Veeva Vault CRM suite, which integrates commercial, marketing, and medical teams. This interconnected approach improves the quality of interactions, aligning strategies with regulatory requirements and ensuring that clients receive the necessary support promptly. This model is crucial in an industry that faces the constant challenge of rapid changes in healthcare regulations and market dynamics.

Veeva Systems is dedicated to promoting innovation and excellence within the life sciences domain. The company provides a cloud-based platform that encompasses applications, instruments, data, and consulting services tailored to the specific needs of the industry. With a client roster that exceeds 1,500, including major biopharmaceutical corporations and emerging biotechs, Veeva is positioned as a critical player in facilitating advancements in the life sciences.

Commitment to Stakeholders

As a true public utility, Veeva is committed to balancing the interests of all stakeholders including clients, employees, shareholders, and the industries it serves. The company's mission is to drive successful outcomes for its clients while improving the pathways through which medical advancements reach patients. By harnessing the capabilities of Vault CRM, Veeva aims to bridge gaps between development and distribution, ensuring that innovative therapies are accessible to those who need them urgently.

Veeva's current trajectory indicates a robust growth strategy supported by ongoing client commitments and the evolving market demands. The integration of AI technology within Vault CRM accentuates its relevance, as the platform continues to adapt to modern requirements, enhancing the overall experience for sales teams and healthcare providers alike.

For more information about Veeva Systems and its offerings, please visit veeva.com.